Mode
Text Size
Log in / Sign up

Neuromuscular training reduces ACL injury risk in athletes: meta-analysisNeuromuscular training cuts ACL injury risk in athletes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider neuromuscular training to reduce ACL injury risk in athletes, based on meta-analytic evidence.

This systematic review and meta-analysis synthesized data from 19 studies to evaluate the effect of neuromuscular training (NMT) on the incidence of anterior cruciate ligament (ACL) injury in athletes. The primary outcome was ACL injury incidence.

The pooled analysis demonstrated that NMT significantly reduced the risk of ACL injury, with an odds ratio of 0.456 (95% CI: 0.331-0.627; p < 0.001). This indicates a substantial protective effect, though the absolute risk reduction was not reported.

The authors did not specify limitations in the provided data, but meta-analyses often face heterogeneity across studies in training protocols, populations, and follow-up durations. No information on adverse events, funding, or conflicts of interest was reported.

Clinicians may consider incorporating NMT into injury prevention programs for athletes, particularly given the strong statistical significance. However, the absence of absolute risk data and potential study heterogeneity warrant cautious interpretation. Further research should clarify optimal training components and long-term outcomes.

A new analysis of 19 studies involving athletes found that neuromuscular training (NMT) significantly reduces the risk of anterior cruciate ligament (ACL) injuries. The analysis, a systematic review and meta-analysis, showed that athletes who did NMT were about half as likely to suffer an ACL injury compared to those who did not. The results were strong and consistent across the studies.

Neuromuscular training includes exercises that improve balance, strength, and movement control. It is often used in sports injury prevention programs. The analysis did not report any side effects or safety concerns, but not all studies may have tracked them.

It is important to note that this is a meta-analysis, which combines results from multiple studies. While the findings are promising, the quality of the individual studies can vary. Also, the analysis did not specify the exact type or amount of training that works best.

For athletes and coaches, this adds to the evidence that NMT can be a valuable part of injury prevention. However, it is not a guarantee against injury. Anyone considering a training program should talk to a sports medicine professional.

What this means for you:
Neuromuscular training may cut ACL injury risk by more than half in athletes.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
ObjectiveAnterior cruciate ligament (ACL) injuries are common in competitive sports and may lead to long-term functional impairment and substantial career burden. Neuromuscular training (NMT) has been proposed to reduce the risk of ACL injury; however, whether its preventive effectiveness differs by age remains controversial. This systematic review and meta-analysis quantitatively evaluated the protective effects of NMT across different age groups.MethodsFive databases were systematically searched for studies evaluating the effect of NMT on the incidence of ACL injury. Pooled effects were synthesized using random-effects models and reported as odds ratios (ORs) with 95% confidence intervals (CIs). Age-stratified subgroup analyses and meta-regression (using the study-level mean age as a continuous moderator) were conducted to explore potential age-related differences in effectiveness.ResultsA total of 19 studies met the inclusion criteria and contributed to the primary meta-analysis. The random-effects meta-analysis showed that NMT significantly reduced ACL injury risk (OR = 0.456, 95% CI: 0.331–0.627, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.